South and Central America Extracellular Matrix Market is expected to reach US$ 11,708.44 thousand by 2027

Market for Vascular Repair and Reconstruction Segment to Grow at Highest CAGR during 2020–2027

According to our latest study on “South and Central America Extracellular Matrix Market Forecast to 2027– COVID-19 Impact and Regional Analysis – by application, and raw material,” the market was valued at US$ 989.99 thousand in 2019 and is projected to reach US$ 11,708.44 thousand by 2027; it is expected to grow at a CAGR of 7.1% during 2020–2027. The report highlights trends prevailing in the South and Central America extracellular matrix market, and the drivers and restraints pertaining to the market growth.

Based on application, the South and Central America extracellular matrix market is segmented into vascular repair and reconstruction, dural repair, wound healing, cardiac repair, pericardial repair and soft tissue repair. The soft tissue repair segment held the largest share of the market in 2019. However, the vascular repair and reconstruction segment is estimated to register the highest CAGR during the forecast period. The growth of the vascular repair and reconstruction segment is driven by increasing accidents and trauma cases. Moreover, the COVID-19 outbreak is negatively impacting the overburdened and underfunded healthcare systems of South and Central America. Hospitals are already overstressed by the treatment of vector?borne diseases and community?acquired infections and high rates of non?communicable diseases (NCDs). Since the onset of the COVID-19, the prevention and treatment of NCDs such as diabetes and its associated complications have been critically affected in the region, as per the Pan American Health Organization (PAHO).

The growth of the South and Central America extracellular matrix market is attributed to increasing incidences of trauma and cardiovascular diseases, and increasing vascular reconstruction procedures. However, the challenges associated with the usage of decellularized extracellular matrix such as, insufficient preservation of vasculature and extracellular matrix composition restrain the growth of the market. Organogenesis Inc., Integra Life Sciences Corporation, Mölnlycke Health Care AB, Anika Therapeutics, Inc., ACell Inc., MIROMATRIX MEDICAL Inc, Acera Surgical Inc., CorMatrix, Inc., Hollister Incorporated, MLM Biologics Inc., and Harbor MedTech, Inc are among the leading companies operating in the South and Central America extracellular matrix market.

South and Central America Extracellular Matrix Market, By Country, 2019 (%)

---

South and Central America Extracellular Matrix Market to Grow at a CAGR of 7.1% to reach US$ 11,708.44 thousand from 2020 to 2027

Download Free Sample

---

South and Central America Extracellular Matrix Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Application (Vascular Repair and Reconstruction, Dural Repair, Wound Healing, Cardiac Repair, Pericardial Repair, Soft Tissue Repair); Raw Material (Bovine, Porcine, Other Raw Material), and Country

The report segments South and Central America extracellular matrix market as follows:

By Application

• Vascular Repair and Reconstruction
• Dural Repair
• Wound Healing
• Cardiac Repair
• Pericardial Repair
• Soft Tissue Repair

By Raw Material

• Bovine
• Porcine
• Others

By Country

• Brazil
• Argentina
• Central America
  • El Salvador
  • Guatemala
  • Rest of Central America
• RoSCAM